Ginkgo Bioworks Holdings Stock Current Liabilities
| DNA Stock | USD 0.85 0.02 2.78% |
Ginkgo Bioworks Holdings fundamentals help investors to digest information that contributes to Ginkgo Bioworks' financial success or failures. It also enables traders to predict the movement of Ginkgo Stock. The fundamental analysis module provides a way to measure Ginkgo Bioworks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ginkgo Bioworks stock.
As of April 24, 2024, Total Current Liabilities is expected to decline to about 128.7 M. In addition to that, Non Current Liabilities Total is expected to decline to about 371.9 M. Ginkgo | Current Liabilities |
Ginkgo Bioworks Holdings Company Current Liabilities Analysis
Ginkgo Bioworks' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Ginkgo Bioworks Current Liabilities | 3.1 B |
Most of Ginkgo Bioworks' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ginkgo Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Ginkgo Bioworks is extremely important. It helps to project a fair market value of Ginkgo Stock properly, considering its historical fundamentals such as Current Liabilities. Since Ginkgo Bioworks' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ginkgo Bioworks' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ginkgo Bioworks' interrelated accounts and indicators.
Click cells to compare fundamentals
Ginkgo Current Liabilities Historical Pattern
Today, most investors in Ginkgo Bioworks Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ginkgo Bioworks' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ginkgo Bioworks current liabilities as a starting point in their analysis.
Ginkgo Bioworks Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Ginkgo Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Ginkgo Bioworks Holdings has a Current Liabilities of 3.1 B. This is 76.63% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 60.83% higher than that of the company.
Ginkgo Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ginkgo Bioworks' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics of similar companies.Ginkgo Bioworks is currently under evaluation in current liabilities category among related companies.
Ginkgo Fundamentals
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (5.16) % | ||||
| Current Valuation | 984.4 M | ||||
| Shares Outstanding | 1.65 B | ||||
| Shares Owned By Insiders | 6.70 % | ||||
| Shares Owned By Institutions | 83.30 % | ||||
| Number Of Shares Shorted | 270.83 M | ||||
| Price To Earning | 25.51 X | ||||
| Price To Book | 1.98 X | ||||
| Price To Sales | 8.65 X | ||||
| Revenue | 251.46 M | ||||
| Gross Profit | 273.49 M | ||||
| EBITDA | (600.68 M) | ||||
| Net Income | (892.87 M) | ||||
| Cash And Equivalents | 1.32 B | ||||
| Cash Per Share | 0.84 X | ||||
| Total Debt | 241.77 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 11.84 X | ||||
| Book Value Per Share | 0.55 X | ||||
| Cash Flow From Operations | (295.5 M) | ||||
| Short Ratio | 11.02 X | ||||
| Earnings Per Share | (0.46) X | ||||
| Target Price | 1.92 | ||||
| Number Of Employees | 1.22 K | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 1.87 B | ||||
| Total Asset | 1.67 B | ||||
| Retained Earnings | (5.29 B) | ||||
| Working Capital | 837.89 M | ||||
| Current Asset | 10.07 B | ||||
| Current Liabilities | 3.1 B | ||||
| Net Asset | 1.67 B |
About Ginkgo Bioworks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ginkgo Bioworks Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ginkgo Bioworks Investors Sentiment
The influence of Ginkgo Bioworks' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ginkgo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ginkgo Bioworks.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ginkgo Bioworks in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ginkgo Bioworks' short interest history, or implied volatility extrapolated from Ginkgo Bioworks options trading.
Pair Trading with Ginkgo Bioworks
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.Moving against Ginkgo Stock
| 0.63 | ELYM | Eliem Therapeutics | PairCorr |
| 0.62 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.61 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.58 | XFOR | X4 Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
| 0.56 | NRSNW | NeuroSense Therapeutics | PairCorr |
The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Ginkgo Bioworks Piotroski F Score and Ginkgo Bioworks Altman Z Score analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.